IN2012DN06280A - - Google Patents

Download PDF

Info

Publication number
IN2012DN06280A
IN2012DN06280A IN6280DEN2012A IN2012DN06280A IN 2012DN06280 A IN2012DN06280 A IN 2012DN06280A IN 6280DEN2012 A IN6280DEN2012 A IN 6280DEN2012A IN 2012DN06280 A IN2012DN06280 A IN 2012DN06280A
Authority
IN
India
Application number
Inventor
Peter John Campbell
Original Assignee
Genome Res Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genome Res Ltd filed Critical Genome Res Ltd
Publication of IN2012DN06280A publication Critical patent/IN2012DN06280A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809Methods for determination or identification of nucleic acids involving differential detection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IN6280DEN2012 2009-12-17 2012-07-17 IN2012DN06280A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0922006.2A GB0922006D0 (en) 2009-12-17 2009-12-17 Diagnostic
PCT/GB2010/052110 WO2011073665A1 (en) 2009-12-17 2010-12-16 Diagnostic methods based on somatically acquired rearrangement

Publications (1)

Publication Number Publication Date
IN2012DN06280A true IN2012DN06280A (en) 2015-09-25

Family

ID=41717068

Family Applications (1)

Application Number Title Priority Date Filing Date
IN6280DEN2012 IN2012DN06280A (en) 2009-12-17 2012-07-17

Country Status (11)

Country Link
US (1) US20130122010A1 (en)
EP (1) EP2513330B1 (en)
JP (1) JP5963679B2 (en)
CN (1) CN102939389B (en)
BR (1) BR112012014996A8 (en)
CA (1) CA2784613C (en)
DK (1) DK2513330T3 (en)
ES (1) ES2627961T3 (en)
GB (1) GB0922006D0 (en)
IN (1) IN2012DN06280A (en)
WO (1) WO2011073665A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8710012B2 (en) 2003-07-14 2014-04-29 Cls Therapeutics Limited Method for treating oncological diseases
US8388951B2 (en) 2003-07-14 2013-03-05 Cls Therapeutics Limited Method for treating systemic DNA mutation disease
US9248166B2 (en) 2003-07-14 2016-02-02 Cls Therapeutics Limited Method for treating oncological diseases
US8431123B2 (en) 2003-07-14 2013-04-30 Cls Therapeutics Limited Method for treating systemic bacterial, fungal and protozoan infection
EP1880733A4 (en) 2005-04-25 2009-08-12 Genkin Dmitry Dmitrievich METHOD FOR EXTENDING THE LIFE OF A HUMAN AND ANIMALS
KR20090087095A (en) 2006-11-28 2009-08-14 드미트리 드미트리에비치 겐킨 Methods for treating human diseases associated with increased deoxyribonucleic acid content in the extracellular space of tissues and pharmaceutical agents for carrying out the methods
US20130210645A1 (en) * 2010-02-18 2013-08-15 The Johns Hopkins University Personalized tumor biomarkers
US11261494B2 (en) * 2012-06-21 2022-03-01 The Chinese University Of Hong Kong Method of measuring a fractional concentration of tumor DNA
WO2015050919A1 (en) 2013-10-01 2015-04-09 Life Technologies Corporation Systems and methods for detecting structural variants
JP6195682B2 (en) * 2014-05-30 2017-09-13 ナントミクス,エルエルシー Systems and methods for comprehensive analysis of molecular images across multiple tumors and germline exomes
US10617743B2 (en) 2014-06-19 2020-04-14 Cls Therapeutics Limited Method to improve safety and efficacy of anti-cancer therapy
SG11201706529TA (en) 2015-02-10 2017-09-28 Univ Hong Kong Chinese Detecting mutations for cancer screening and fetal analysis
RU2726131C2 (en) 2015-05-22 2020-07-09 Дмитрий Дмитриевич Генкин Extracellular dna as a therapeutic target in neurodegeneration
EP3433373B1 (en) 2016-03-22 2022-01-12 Myriad Women's Health, Inc. Combinatorial dna screening
WO2017181146A1 (en) 2016-04-14 2017-10-19 Guardant Health, Inc. Methods for early detection of cancer
ES2990117T3 (en) 2017-01-25 2024-11-28 Univ Hong Kong Chinese Diagnostic applications using nucleic acid fragments
ES2959360T3 (en) 2017-07-26 2024-02-23 Univ Hong Kong Chinese Improving cancer screening using acellular viral nucleic acids
US11905522B2 (en) 2018-01-16 2024-02-20 Cls Therapeutics Limited Treatment of diseases by liver expression of an enzyme which has a deoxyribonuclease (DNase) activity

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030175713A1 (en) * 2002-02-15 2003-09-18 Clemens Sorg Method for diagnosis of inflammatory diseases using CALGRANULIN C
JP2006515318A (en) * 2002-10-29 2006-05-25 ファルマシア・コーポレーション Specifically associated cancer-related gene, polypeptide encoded thereby and method of use thereof
FR2863274B1 (en) * 2003-12-05 2012-11-16 Commissariat Energie Atomique METHOD FOR QUANTITATIVE EVALUATION OF REARRANGEMENT OR TARGETED GENETIC RECOMBINATION OF AN INDIVIDUAL AND APPLICATIONS THEREOF
US8039210B2 (en) * 2004-05-14 2011-10-18 The Johns Hopkins University Protein tyrosine phosphatase mutations in cancers
JP2009502159A (en) * 2005-07-28 2009-01-29 オンコステム ファルマ ソシエダッド リミタード Staged expression of snails as a marker of cancer growth and disease based on DNA damage
US20070238094A1 (en) * 2005-12-09 2007-10-11 Baylor Research Institute Diagnosis, prognosis and monitoring of disease progression of systemic lupus erythematosus through blood leukocyte microarray analysis
CN1995384A (en) * 2006-01-06 2007-07-11 王铸钢 Quick and convenient authentication technology fro transgenic insert locus
CN101153340A (en) * 2007-09-30 2008-04-02 中国农业大学 A method for detection of junction fragment PCR for identification of unknown gene sequence
JPWO2009057695A1 (en) * 2007-10-30 2011-03-10 オリンパス株式会社 Method for detecting adenoma or cancer by genetic analysis

Also Published As

Publication number Publication date
GB0922006D0 (en) 2010-02-03
BR112012014996A8 (en) 2018-04-03
CA2784613C (en) 2018-03-06
US20130122010A1 (en) 2013-05-16
EP2513330A1 (en) 2012-10-24
CA2784613A1 (en) 2011-06-23
DK2513330T3 (en) 2017-06-19
CN102939389B (en) 2016-11-16
EP2513330B1 (en) 2017-03-08
CN102939389A (en) 2013-02-20
JP2013514075A (en) 2013-04-25
ES2627961T3 (en) 2017-08-01
JP5963679B2 (en) 2016-08-03
WO2011073665A1 (en) 2011-06-23
BR112012014996A2 (en) 2017-01-31

Similar Documents

Publication Publication Date Title
BE2015C040I2 (en)
BR112012008195A2 (en)
BR112012003062A2 (en)
BRPI0924307A2 (en)
BR112012008267A2 (en)
BR112012012396A2 (en)
BR112012000607A2 (en)
BR122021004633A2 (en)
BR112012000665A2 (en)
BR112012012487A2 (en)
BR112012003080A2 (en)
BR112012003853A2 (en)
BRPI0924534A2 (en)
BR112012009797A2 (en)
BR112012009446A2 (en)
BR112012009703A2 (en)
BR112012001263A2 (en)
BR112012010357A2 (en)
BR112012007656A2 (en)
BR112012014856A2 (en)
BR112012000159A2 (en)
BR112012002627A2 (en)
BR112012005951A2 (en)
BR112012007672A2 (en)
BR112012000156A2 (en)